The largest database of trusted experimental protocols

Avanti j 20xpi

Manufactured by Beckman Coulter
Sourced in United States

The Avanti J-20XPI is a high-performance centrifuge designed for a wide range of laboratory applications. It features a maximum speed of 20,000 RPM and a maximum RCF of 50,803 x g. The centrifuge is capable of accommodating sample volumes up to 1 liter. It is equipped with a durable, corrosion-resistant rotor chamber and a powerful brushless motor for efficient and reliable operation.

Automatically generated - may contain errors

6 protocols using avanti j 20xpi

1

Purification and Characterization of Melanin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The produced melanin was purified in a two-step process by acidic precipitation. A 5 M HCl solution was added to 400 mL of supernatant to reach pH 1.5, according to previously reported protocols [14 (link),21 (link)]. The samples were kept at 4 °C overnight and then centrifuged at 4 °C and 5000 rpm for 20 min (Avanti J-20XPI, Beckman Coulter, Brea, CA, USA). The precipitated melanin was then washed three times with MilliQ water, recovered each time by centrifugation as described above, and then dried at room temperature. A portion of the precipitated dried melanin (about 15.0%) was then further washed with a 5 M HCl solution under stirring conditions and at room temperature for 5 h, using a slightly modified protocol [12 (link),20 (link)]. This wash was performed to remove the eventual presence of proteins and nucleic acids bonded to the pigment. The sample was then centrifuged at 4 °C and 4500 rpm for 20 min (Avanti J-20XPI, Beckman Coulter, Brea, CA, USA), and the residual precipitated melanin was washed again three times with MilliQ water, dried as described above, and further used for characterization.
+ Open protocol
+ Expand
2

Cultivation of Streptomyces nashvillensis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Streptomyces nashvillensis DSM 40314 was purchased from DSMZ (Braunschweig, Germany) and initially grown in a 1-L shake flask containing 200 mL of GYA medium (glucose (20.0 g/L), yeast extract (20.0 g/L), (NH4)2SO4 (2.0 g/L), NaH2PO4·H2O (5.8 g/L), Na2HPO4 (8.2 g/L) at pH 7.0), at 28 °C and under constant agitation of 250 rpm in a rotary air shaker (ISF-1-W, Kühner, Birsfelden (Basel), Switzerland) [25 (link)]. After 48 h of growth, the culture was centrifuged at 4 °C and 5000 rpm (Avanti J-20XPI, Beckman Coulter, Brea, CA, USA) and then resuspended in fresh GYA medium with 20% (v/v) glycerol to prepare cell stock solutions, according to a previously reported procedure [25 (link)]. The stocks were then stored at −80 °C. Bacterial growth was carried out in GEM III N medium at different pH conditions (6.0 or 7.0) (glucose (12.0 g/L), yeast extract (6.0 g/L), malt extract (30.0 g/L), with a buffer phosphate made of NaH2PO4·H2O (11.9 g/L), Na2HPO4 (1.9 g/L) for pH 6.0 or NaH2PO4·H2O (5.8 g/L), and Na2HPO4 (8.2 g/L) for pH 7.0) [25 (link)]. The media, devoid of glucose and Na2HPO4, was sterilized by autoclaving at 120 °C for 20 min (ALFA-junior, PBI International, Milano, Italy). Solutions of glucose and Na2HPO4, sterilized by filtration with 0.22 µm membranes (Merck Millipore, Guyancourt, France), were added later to the autoclaved media.
+ Open protocol
+ Expand
3

Isolation and Labeling of Neuronal Nuclei

Check if the same lab product or an alternative is used in the 5 most similar protocols
Postmortem SVZ human brain tissue samples were thawed on ice and transferred into a 1.5 mL Eppendorf tube. Tissue was homogenized in nuclear extraction buffer (0.32 M Sucrose, 10 mM Tris–HCl pH8.0, 5 mM CaCl2, 3 mM MgCl2, 1 mM DTT, 0.1 mM EDTA and 0.1% Triton X-100) using a disposable pellet pestle (∼30 strokes).
Nuclei were isolated by using a discontinuous sucrose gradient. The homogenized tissue solution was transferred into a 50 mL centrifuge tube (3115-0050, Thermo Fisher Scientific) and a sucrose solution (1.8 M sucrose, 10 mM Tris–HCl pH8.0, 3 mM MgCl2 and 1 mM DTT) was added at the bottom to form the gradient. Samples were centrifuged at 75600 × g at 10°C, for 1 h in a Beckman Coulter centrifuge Avanti J-20 XPI with a fixed angle JA-25.50 rotor. Nuclei were stained with a mouse anti-neuronal nuclei (NeuN) Alexa Fluor 488 conjugated monoclonal antibody (Alexa488NeuN antibody) (MAB377X, Millipore) and DAPI (D1306, Thermo Fisher Scientific).
+ Open protocol
+ Expand
4

Recombinant G-CSF expression and formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
G-CSF (accession
code M17706) was expressed as inclusion bodies in Escherichia
coli
BL21 (DE3) cells (New England Laboratories, Massachusetts,
USA) harboring a modified pET21A plasmid (Novagen, Wisconsin, USA),
and confirmed by intact mass spectrometry (LC-MS), exactly as described
previously.18 (link) Briefly, cells were grown
in 400 mL of Terrific Broth and 1 mM ampicillin, at 37 °C, within
2 L baffled shake flasks, and induced with 1 mM IPTG at OD600 = 0.6. After 3.5 h, cells were pelleted at 5410g for 30 min at 4 °C (Avanti J-20XPI; Beckman Coulter Inc., Fullerton,
California, USA) and then washed, refolded, purified by size exclusion
chromatography, and concentrated to 1.0 mg/mL in 10 mM sodium acetate,
pH 4.25 as described previously.18 (link) For
each new formulation, samples were buffer exchanged into 50 mM citrate
pH 4.25 with 10 kDa cutoff Slide-A-Lyzer Dialysis cassettes (Fisher
Scientific, Leicestershire), mixing 1:1 with sterile-filtered 2×
excipient solutions in 50 mM citrate pH 4.25 to obtain final formulated
0.3 mg/mL G-CSF, and incubated on the bench at RT (22 °C) for
1 h to ensure full equilibration. Monomer, dimer, and aggregate content
was measured using analytical SEC and LC-MS for all G-CSF samples.
+ Open protocol
+ Expand
5

Production of Probiotic Ef 30616 Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
E. faecium Ef 30616 was inoculated in 200 mL of 0.22 µm filter-sterilized modified De Man, Rogosa and Sharpe (MRS) medium (VWR International, Mississauga, Ontario, Canada). This bottle culture was incubated without shaking at 37 ± 1 °C for 18 h. The culture was then used to inoculate 4 L of chemically defined medium (CDM) with 200 g whey protein isolate (Canadian Protein) and 25 g lactose. The vessel culture was incubated statically at 37 ± 1 °C for 48 h. Following incubation, the Ef 30616 cells were isolated from the liquid phase by centrifugation at 12,000× g for 30 min at 4 °C (Avanti J-20 XPI, Beckman Coulter, Canada). The cell-free supernatant containing the probiotic metabolites was then frozen at − 80 °C and freeze dried. The dried Ef 30616 cell-free supernatant was kept in long-term storage in powder form at − 20 °C until needed.
+ Open protocol
+ Expand
6

Recombinant G-CSF Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids for wild-type G-CSF (accession code M17706), and the variants were transformed into E. coli BL21 (DE3) competent cells (New England Laboratories, MA, USA) for expression of GCSF as inclusion bodies (IBs), as described previously [22] , but with some minor modifications as detailed here. Briefly, cells were grown in 2 L baffled shake flasks containing 400 mL of Terrific Broth, 1 mM Ampicillin, at 37 °C. Expression was induced at mid-exponential growth (OD600= 0.6), with 1 mM IPTG. Cells were harvested 3.5 h post-induction by centrifugation at 5410 x g, 30 mins, and 4 °C (Avanti J-20 XPI; Beckman Coulter Inc., Fullerton, CA, USA). Pellets were washed, refolded and purified using a preparatory size exclusion chromatography column exactly as described previously [22] , giving final proteins concentrated to 1.0 mg/mL in 10 mM sodium acetate, pH 4.25. Analytical SEC and LC-MS determined the aggregate, monomer and dimer content of all G-CSF variant samples.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!